Barbara Gayle Duncan, Chief Financial Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 53 shares at $238.16 ($13K) on 2015-07-02, disclosed to the SEC on 2015-07-07.
Open-market sale of $13k ICPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $236.13 | 50 | $12K | 94.3% |
| 2 | $238.16 | 2 | $476 | 3.8% |
| 3 | $239.00 | 1 | $239 | 1.9% |
| Total | $236.26 avg | 53 | $13K | 100% |
| Filing → |
| JNCE | SELL | 2018-01-29 | $100K | — | Filing → |
| GNMX | BUY | 2017-10-18 | $150K | — | Filing → |
| ICPT | SELL | 2016-10-05 | $24K | — | Filing → |